bioAffinity Technologies
BIAF
10 hedge funds and large institutions have $484K invested in bioAffinity Technologies in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
110% more capital invested
Capital invested by funds: $231K → $484K (+$254K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
25% more funds holding
Funds holding: 8 → 10 (+2)
0.45% more ownership
Funds ownership: 1.64% → 2.09% (+0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.7K |
| 2 |
Renaissance Technologies
New York
|
+$65K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$23.5K |
| 4 |
SBIA
Sheaff Brock Investment Advisors
Indianapolis,
Indiana
|
+$17.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$31.8K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$21.1K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$8 |
BIAF Hedge Fund Activity: Q1 2024 in Review
10 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q1 2024, worth a combined $484K — up 110% from $231K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BIAF positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $87.7K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $31.8K sold.
- 10 institutional investors held bioAffinity Technologies (BIAF) as of Q1 2024, up from 8 in Q4 2023.
- Funds reported $484K of bioAffinity Technologies stock for Q1 2024, up 110% quarter-over-quarter.
- 3 funds opened new bioAffinity Technologies positions in Q1 2024 and 1 closed out, a net change of +2 holders.
- The largest bioAffinity Technologies buyer in Q1 2024 was Vanguard Group, an estimated $87.7K added.
- The largest bioAffinity Technologies seller in Q1 2024 was Two Sigma Investments, an estimated $31.8K sold.
Based on aggregated 13F filings for Q1 2024.